Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia

NCT03226418 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Adult Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia
Therapy-Related Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Decitabine
DRUG: Idarubicin
OTHER: Laboratory Biomarker Analysis
DRUG: Liposome-encapsulated Daunorubicin-Cytarabine
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Azacitidine
DRUG: Venetoclax
DRUG: glasdegib

Sponsor

University of Nebraska

Collaborators

[object Object]